In support of this possibility, previous studies revealed an increased expression of activation markers on peripheral lymphocytes of SLE patients, including phosphorylated ERK, JNK and p38 which are prerequisite for subsequent activation of Elk-1 [38], [39]. The gene discussed is ELK1; the disease is systemic lupus erythematosus.